Who are Bioxytran, Inc.'s main suppliers?

Bioxytran, Inc. (BIXT) key suppliers include: PHARMALECTIN-BVI-INC, PHARMALECTIN-INC, PHARMALECTIN-INDIA-PVT-LTD, AUCTUS-FUND-LLC, LENDER and 3 more. View the full supplier network at chainsifter.com/chain/BIXT.

Who are Bioxytran, Inc.'s major customers?

Bioxytran, Inc. (BIXT) key customers include: KHOURY-MEDICAL-LTD, PHARMALECTIN-INC, MDX-LIFESCIENCES-INC, NDPD-PHARMA-INC, PHARMALECTIN-PARTNERS-LLC. View the full customer network at chainsifter.com/chain/BIXT.

What sector is Bioxytran, Inc. in?

Bioxytran, Inc. (BIXT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

BIXT Supply Chain: Bioxytran, Inc. Supplier List & 15 Relationships

8Suppliers

5Customers

2Debt Items

0Related Chains

Bioxytran, Inc. Suppliers

Ticker	Name	Confidence	Evidence
PHARMALECTIN-BVI-INC	PHARMALECTIN-BVI-INC	85%	The Company holds a License Agreement (the “License” or “Agreement”) for a medical device (license obtained in 2019) with an affiliated company in which Company officers hold a majority interest.
PHARMALECTIN-INC	PHARMALECTIN-INC	85%	The Company holds a License Agreement (the “License” or “Agreement”) for a medical device (license obtained in 2019) with an affiliated company in which Company officers hold a majority interest.
PHARMALECTIN-INDIA-PVT-LTD	PHARMALECTIN-INDIA-PVT-LTD	85%	The Company holds a License Agreement (the “License” or “Agreement”) for a medical device (license obtained in 2019) with an affiliated company in which Company officers hold a majority interest.
AUCTUS-FUND-LLC	AUCTUS-FUND-LLC	80%	10.53 Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated February 25, 2019
LENDER	LENDER	80%	10.82 Securities Purchase Agreement between Bioxytran, Inc. and Lender, dated March 15, 2024
POWER-UP-LENDING-GROUP-LLC	POWER-UP-LENDING-GROUP-LLC	80%	10.53 Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated February 25, 2019
RESOURCES-UNLIMITED-NW-LLC	RESOURCES-UNLIMITED-NW-LLC	80%	10.23 Investor Relations Agreement between Bioxytran, Inc. and Resources Unlimited NW LLC. dated April 22, 2019.
TRITON-FUNDS-LP	TRITON-FUNDS-LP	80%	10.76 Form of Closing Agreement with TRITON FUNDS LP, dated June 8, 2023

Bioxytran, Inc. Customers

Ticker	Name	Confidence	Evidence
KHOURY-MEDICAL-LTD	KHOURY-MEDICAL-LTD	92%	Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR® Dietary Supplement
PHARMALECTIN-INC	PHARMALECTIN-INC	90%	10.59 License Agreement between Bioxytran, Inc. and Pharmalectin, Inc. dated May 5, 2020
MDX-LIFESCIENCES-INC	MDX-LIFESCIENCES-INC	80%	10.22 License Agreement between Bioxytran, Inc. and MDX Lifesciences, Inc. dated April 4, 2019.
NDPD-PHARMA-INC	NDPD-PHARMA-INC	80%	10.60 License Agreement between Pharmalectin, Inc. and NDPD Pharma, Inc. dated May 2, 2021
PHARMALECTIN-PARTNERS-LLC	PHARMALECTIN-PARTNERS-LLC	80%	10.57 Joint Venture Agreement between Bioxytran and Pharmalectin Partners, LLC, dated November 15, 2020.

Bioxytran, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BIXT-DEBT-8215	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2026-03-31.
BIXT-DEBT-8214	Warrants outstanding: 15383334	90%	xbrl warrant detail from xbrl 2026-03-31.

Bioxytran, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bioxytran, Inc..

Bioxytran, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Bioxytran, Inc..

Bioxytran, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Bioxytran, Inc. Supply Chain